Journal profile · Medicine, Research & Experimental
JOURNAL OF MOLECULAR MEDICINE-JMM
ISSN 0946-2716 · eISSN 1432-1440 · Springer Berlin Heidelberg · GERMANY · Monthly · Founded 1922
JOURNAL OF MOLECULAR MEDICINE-JMM: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 4.98; hybrid open access; APC about USD 4,390; median 192 days to acceptance (100 articles, last 24 months); community-reported acceptance: about 25%; 116 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
JOURNAL OF MOLECULAR MEDICINE-JMM is published by Springer Berlin Heidelberg and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Biomedical and Chemical Research, Medical and Health Sciences Research and Psychology, Coaching, and Therapy, together about 36.1% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
The Journal of Molecular Medicine publishes original research articles and review articles that range from basic findings in mechanisms of disease pathogenesis to therapy. The focus includes all human diseases, including but not limited to: Aging, angiogenesis, autoimmune diseases as well as other inflammatory diseases, cancer, cardiovascular diseases, development and differentiation, endocrinology, gastrointestinal diseases and hepatology, genetics and epigenetics, hematology, hypoxia research, immunology, infectious diseases, metabolic disorders, neuroscience of diseases, -omics based disease research, regenerative medicine, and stem cell research. Studies solely based on cell lines will not be considered. Studies that are based on model organisms will be considered as long as they are directly relevant to human disease.
Source: LetPub
Research area (LetPub): Medicine, Research & Experimental
Main research topics OpenAlex counts of recent articles; shares are approximate
- Biomedical and Chemical ResearchMedicine16.3%
- Medical and Health Sciences ResearchMedicine10.8%
- Psychology, Coaching, and TherapyPsychology9%
- European history and politicsSocial Sciences7.1%
- Sports Science and EducationArts and Humanities6.1%
- Health and Medical StudiesHealth Professions4.7%
- Metabolism and Genetic DisordersBiochemistry, Genetics and Molecular Biology4.3%
- Medical History and ResearchArts and Humanities4.2%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Genetics & Heredity | Zone 3 |
| Minor | Medicine, Research & Experimental | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Genetics & Heredity | Zone 2 |
| Minor | Medicine, Research & Experimental | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Genetics & Heredity | Zone 3 |
| Minor | Medicine, Research & Experimental | Zone 3 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 4.98LetPub ·
- CiteScore 2026-06
- 8.6LetPub ·
- SJR 2026-06
- 1.4LetPub ·
- SNIP 2026-06
- 1LetPub ·
- h-index
- 127LetPub ·
- h-index
- 201OpenAlex ·
- i10-index
- 9,189OpenAlex ·
- 2-year mean citedness
- 4.94OpenAlex ·
- Self-citation rate
- 2%LetPub ·
- Share of gold OA articles
- 37.5%LetPub ·
Volume
- Articles per year
- 111LetPub ·
Articles by year OpenAlex count · 40,027 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 96 | 49 | 52 |
| 2025 | 116 | 48 | 381 |
| 2024 | 100 | 48 | 1,108 |
| 2023 | 128 | 57 | 1,850 |
| 2022 | 108 | 51 | 2,052 |
| 2021 | 154 | 87 | 4,191 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
192 daysMedian, submission to acceptance · P25–P75 139 days – 278 days
- Acceptance to online
- median 16 days (100 articles)
- Submission to online
- median 209 days
- Sample
- 100 articles with submission and acceptance dates (228 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 1.3 monthsLetPub ·
- Average acceptance (community reports)
- 25%LetPub ·
- Peer review
- Double anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,390 / EUR 3,690 / GBP 2,890 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare5 items from the author guidelines
- Abstract
- ≥ 150 words
- Keywords
- ≥ 4
- Manuscript length
- ≤ 3,500 words
- Reference style
- Numbered, in order of citation
- Suggested reviewers
- Optional
Article types accepted5, with length limits
- commentaryThe following types of articles will be considered for publication: J Mol Med publishes original articles, review articles, commentaries and editorials. Manuscr…main text ≤ 1,000 words
- editorialThe following types of articles will be considered for publication: J Mol Med publishes original articles, review articles, commentaries and editorials. Manuscr…Length not stated
- original articleThe following types of articles will be considered for publication: J Mol Med publishes original articles, review articles, commentaries and editorials. Manuscr…main text ≤ 3,500 words
- reviewThe following types of articles will be considered for publication: J Mol Med publishes original articles, review articles, commentaries and editorials. Manuscr…Length not stated
- review articleThe following types of articles will be considered for publication: J Mol Med publishes original articles, review articles, commentaries and editorials. Manuscr…Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Data availability, Publication ethics, License & copyright, Open access, Peer review
- AI use Generative AI Images
Please check Springer’s policy on generative AI images and make sure your work adheres to the principles described therein. Back to top
Source ↗Publisher website ·- Authorship Authorship principles
These guidelines describe authorship principles and good authorship practices to which prospective authors should adhere to. Authorship clarified The Journal and Publisher assume all authors agreed with the content and that all gave explicit consent to submit and that they obtained consent from the responsible authorities at the institute/organization where the work has been carried out, before th…
Source ↗Publisher website ·- Conflicts of interest Disclosures and declarations
All authors are requested to include information regarding sources of funding, financial or non-financial interests, study-specific approval by the appropriate ethics committee for research involving humans and/or animals, informed consent if the research involved human participants, and a statement on welfare of animals if the research involved animals (as appropriate). The decision whether such …
Source ↗Publisher website ·- Data availability Data Availability
All original research must include a Data Availability Statement. Data Availability Statements should provide information on where data supporting the results reported in the article can be found. Statements should include, where applicable, hyperlinks to publicly archived datasets analysed or generated during the study. When it is not possible to share research data publicly, for instance when in…
Source ↗Publisher website ·- Publication ethics Ethical standards
Manuscripts submitted for publication must contain a statement to the effect that all human and animal studies have been approved by the appropriate ethics committee and have therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. It should also be stated clearly in the text that all persons gave their informed conse…
Source ↗Publisher website ·- License & copyright Copyright
Open Choice articles do not require transfer of copyright as the copyright remains with the author. In opting for open access, the author(s) agree to publish the article under a Creative Commons license. Details of the OA licences offered to authors can be found on the individual journal website, in the journal's How to publish with us guide. Back to top
Source ↗Publisher website ·- Open access Open access publishing
To find out more about publishing your work Open Access in Journal of Molecular Medicine, including information on fees, funding and licences, visit our Open access publishing page. Back to top
Source ↗Publisher website ·- Peer review Internal Transfers and Portable Peer Review for Transfers Outside of Springer Nature
Submitting Manuscripts with Reviews from Other Journals As part of our goal to improve the efficiency of peer review we are open to considering manuscripts on the basis of reviews received at other journals, including those outside of Springer Nature. Authors wishing to transfer papers with reviews to Journal of Molecular Medicine should email us at jmmoff@uni-mainz.de to enquire about the suitabi…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Springer Berlin Heidelberg
- Country or region
- GERMANY
- Language
- English
- Frequency
- Monthly
- Founded
- 1922
- ISSN
- 0946-2716
- Electronic ISSN
- 1432-1440
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Author guidelines ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about JOURNAL OF MOLECULAR MEDICINE-JMM
What CAS zone is JOURNAL OF MOLECULAR MEDICINE-JMM in?
In the 2025 upgraded edition of the CAS Journal Ranking, JOURNAL OF MOLECULAR MEDICINE-JMM is in Zone 3 of Medicine, and in Zone 3 of the minor category Genetics & Heredity / Medicine, Research & Experimental. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of JOURNAL OF MOLECULAR MEDICINE-JMM?
The latest impact factor listed by LetPub is 4.98; CiteScore 8.6, h-index 201.
How long does peer review take at JOURNAL OF MOLECULAR MEDICINE-JMM?
Based on the dates recorded on 100 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 192 days (interquartile range 139–278 days); authors report an average review time of about 1.3 months; the community-reported acceptance is “about 25%”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of JOURNAL OF MOLECULAR MEDICINE-JMM?
According to the journal's author guidelines: Abstract: ≥ 150 words; Keywords: ≥ 4; Manuscript length: ≤ 3,500 words; Reference style: Numbered, in order of citation; Suggested reviewers: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Which databases index JOURNAL OF MOLECULAR MEDICINE-JMM?
According to LetPub and DOAJ records, JOURNAL OF MOLECULAR MEDICINE-JMM is indexed in SCIE and Scopus.
Is JOURNAL OF MOLECULAR MEDICINE-JMM open access, and what is the APC?
JOURNAL OF MOLECULAR MEDICINE-JMM is a hybrid journal. For open-access publication: APC about USD 4,390.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .